Figure 1.
Schematic representation of the miRNA quantitative analysis (hsa-miR-let-7a, hsa-miR-let-7f, hsa-miR-30a, hsa-miR-486, hsa-miR-223, and hsa-miR-451) in human plasma. DLS—dynamic light scattering, HSFC—high-sensitivity flow cytometry, WB—Western blot, NTA—nanoparticle tracking analysis, LVSEM—low-voltage scanning electron microscopy. The results of DLS analysis of the samples after different treatments were overlaid for comparison purposes.